Last Minute Lecture is a student-run project and is currently funded entirely by students who believe educational resources should remain free and accessible. If Last Minute Lecture has helped you study, please consider supporting the project.
❤️
All chapters are now available for free on our new platform:
📚 Alzheimer disease represents a progressive neurodegenerative condition characterized by irreversible cognitive decline, memory loss, and functional deterioration that ultimately impairs activities of daily living. Although current pharmacological approaches cannot halt neuronal death or reverse disease progression, available medications provide modest symptomatic relief by targeting specific pathophysiological mechanisms underlying cognitive impairment. The underlying neuropathology involves multiple interconnected processes: selective neuronal degeneration beginning in hippocampal structures and extending to cortical regions, dramatic reduction in acetylcholine synthesis and availability, accumulation of extracellular beta-amyloid plaques, and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein. Advanced age represents the strongest epidemiological risk factor, with disease onset typically occurring after age 65, though genetic factors such as apolipoprotein E4 polymorphisms and family history significantly influence susceptibility. Three primary drug classes address cognitive symptoms through distinct mechanisms: cholinesterase inhibitors enhance synaptic acetylcholine by blocking enzymatic degradation, producing modest cognitive benefits in mild to moderate disease stages but causing peripheral cholinergic effects including gastrointestinal disturbance and potentially life-threatening bradycardia; memantine selectively modulates glutamatergic neurotransmission at NMDA receptors to prevent excitotoxic calcium influx while preserving normal memory-related signaling; and monoclonal antibodies targeting beta-amyloid promote immune-mediated plaque clearance but carry significant risks including amyloid-related imaging abnormalities such as cerebral edema and microhemorrhages. Management of behavioral complications including agitation, aggression, and psychotic features typically emphasizes nonpharmacological interventions, with atypical antipsychotics reserved for refractory cases given associated mortality risks. Nursing care priorities encompass baseline functional and cognitive assessment to establish disease trajectory, implementation of fall prevention strategies given cardiovascular medication effects, and intensive neuroimaging surveillance in patients receiving amyloid-targeted immunotherapy to detect subclinical adverse effects.
⚠️ Disclaimer: These summaries are created for educational and entertainment purposes only. They provide transformative commentary and paraphrased overviews to help students understand key ideas from the referenced textbooks. Last Minute Lecture is not affiliated with, sponsored by, or endorsed by any textbook publisher or author. All textbook titles, names, and cover images—when shown—are used under nominative fair use solely for identification of the work being discussed. Some portions of the writing and narration are generated with AI-assisted tools to enhance accessibility and consistency. While every effort has been made to ensure accuracy, these materials are intended to supplement—not replace—official course readings, lectures, or professional study resources. Always refer to the original textbook and instructor guidance for complete and authoritative information.
source